168 related articles for article (PubMed ID: 9443309)
1. The clinical use of rhDNAse.
Davies J; Trindale M; Wallis C; Rosenthal M; Bush A
Pediatr Pulmonol Suppl; 1997; 16():273-4. PubMed ID: 9443309
[No Abstract] [Full Text] [Related]
2. rhDNase in cystic fibrosis.
Tyrrell JC; Lewis PA; Sheldon CD; Connett G
Thorax; 1999 Aug; 54(8):752. PubMed ID: 10490419
[No Abstract] [Full Text] [Related]
3. Multicenter, open-label study of recombinant human DNase in cystic fibrosis patients with moderate lung disease. DNase International Study Group.
Harms HK; Matouk E; Tournier G; von der Hardt H; Weller PH; Romano L; Heijerman HG; FitzGerald MX; Richard D; Strandvik B; Kolbe J; Kraemer R; Michalsen H
Pediatr Pulmonol; 1998 Sep; 26(3):155-61. PubMed ID: 9773909
[TBL] [Abstract][Full Text] [Related]
4. rhDNase therapy for the treatment of cystic fibrosis patients with mild to moderate lung disease.
Christopher F; Chase D; Stein K; Milne R
J Clin Pharm Ther; 1999 Dec; 24(6):415-26. PubMed ID: 10651974
[TBL] [Abstract][Full Text] [Related]
5. Aerosolized deoxyribonuclease for cystic fibrosis.
Med Lett Drugs Ther; 1994 Apr; 36(920):34-5. PubMed ID: 8145672
[No Abstract] [Full Text] [Related]
6. Where we are now with rhDNase.
Geddes DM; Shah PL
Lancet; 1999 May; 353(9166):1727. PubMed ID: 10347981
[No Abstract] [Full Text] [Related]
7. Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial.
Suri R; Metcalfe C; Lees B; Grieve R; Flather M; Normand C; Thompson S; Bush A; Wallis C
Lancet; 2001 Oct; 358(9290):1316-21. PubMed ID: 11684212
[TBL] [Abstract][Full Text] [Related]
8. Early treatment with dornase alfa in cystic fibrosis: what are the issues?
Bush A
Pediatr Pulmonol; 1998 Feb; 25(2):79-82. PubMed ID: 9516089
[No Abstract] [Full Text] [Related]
9. Retrospective review of the effects of rhDNase in children with cystic fibrosis.
Davies J; Trindade MT; Wallis C; Rosenthal M; Crawford O; Bush A
Pediatr Pulmonol; 1997 Apr; 23(4):243-8. PubMed ID: 9141109
[TBL] [Abstract][Full Text] [Related]
10. Consensus conference: practical applications of Pulmozyme. September 22, 1993.
Ramsey BW; Dorkin HL
Pediatr Pulmonol; 1994 Jun; 17(6):404-8. PubMed ID: 8090614
[No Abstract] [Full Text] [Related]
11. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.
Fuchs HJ; Borowitz DS; Christiansen DH; Morris EM; Nash ML; Ramsey BW; Rosenstein BJ; Smith AL; Wohl ME
N Engl J Med; 1994 Sep; 331(10):637-42. PubMed ID: 7503821
[TBL] [Abstract][Full Text] [Related]
12. Effect of rhDNase on lung function and quality of life in adult cystic fibrosis patients.
Heijerman HG; van Rossem RN; Bakker W
Neth J Med; 1995 Jun; 46(6):293-7. PubMed ID: 7643945
[TBL] [Abstract][Full Text] [Related]
13. Nebulised bronchodilators, antibiotics and rhDNase for children with cystic fibrosis.
Spencer DA
Thorax; 1997 Apr; 52 Suppl 2(Suppl 2):S89-91. PubMed ID: 9155860
[No Abstract] [Full Text] [Related]
14. [New pharmacological approaches: rhDNase].
Tournier G; Sardet A; Grosskopf C; Baculard A; Delaisi B
Rev Pneumol Clin; 1995; 51(3):193-200. PubMed ID: 7569583
[TBL] [Abstract][Full Text] [Related]
15. Dornase alfa therapy in cystic fibrosis: who should get it?
Kanga JF
Chest; 1996 Oct; 110(4):871-2. PubMed ID: 8874235
[No Abstract] [Full Text] [Related]
16. Recombinant human deoxyribonuclease for cystic fibrosis.
Jones AP; Wallis CE
Cochrane Database Syst Rev; 2003; (3):CD001127. PubMed ID: 12917899
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive therapy in cystic firbrosis (CF).
Voter KZ
Pediatr Infect Dis J; 1998 Apr; 17(4):341-2. PubMed ID: 9576391
[No Abstract] [Full Text] [Related]
18. Recombinant human DNase (rhDNase) in cystic fibrosis: is it cost effective?
Conway SP
Arch Dis Child; 1997 Jul; 77(1):1-3. PubMed ID: 9279142
[No Abstract] [Full Text] [Related]
19. Aerosolized recombinant human DNase I for the treatment of cystic fibrosis.
Shak S
Chest; 1995 Feb; 107(2 Suppl):65S-70S. PubMed ID: 7842816
[TBL] [Abstract][Full Text] [Related]
20. Effects of recombinant human DNase and hypertonic saline on airway inflammation in children with cystic fibrosis.
Suri R; Marshall LJ; Wallis C; Metcalfe C; Bush A; Shute JK
Am J Respir Crit Care Med; 2002 Aug; 166(3):352-5. PubMed ID: 12153969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]